Get the Stockscreener App
1.90
5.94%
-0.12
Treace Medical Concepts Inc stock is traded at $1.90, with a volume of 552.97K.
It is down -5.94% in the last 24 hours and down -32.14% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
See More
Previous Close:
$2.02
Open:
$2.03
24h Volume:
552.97K
Relative Volume:
0.59
Market Cap:
$121.06M
Revenue:
$198.53M
Net Income/Loss:
$-63.68M
P/E Ratio:
-1.8587
EPS:
-1.0222
Net Cash Flow:
$-41.50M
1W Performance:
-6.86%
1M Performance:
-32.14%
6M Performance:
-70.90%
1Y Performance:
-80.65%
1-Day Range:
$1.885
$2.045
1-Week Range:
$1.885
$2.305
52-Week Range:
$1.885
$10.30
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
1.90 | 128.71M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-25 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-07-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026 - Bitget
Treace Medical Concepts to Release Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 - Quiver Quantitative
Why is Treace Medical Concepts Inc stock going up2025 Retail Activity & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Stockholders to Connect - ACCESS Newswire
Stifel Revises Treace Medical Concepts, Inc. (TMCI) Price Target in Sector-Wide Update - Finviz
11 High Growth Micro-cap Stocks to Buy - Insider Monkey
Treace Medical Concepts (NASDAQ:TMCI) Upgraded at Wall Street Zen - MarketBeat
Johnson Fistel, PLLP Investigates Claims on Behalf of - GlobeNewswire
Institutional owners may consider drastic measures as Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) recent US$29m drop adds to long-term losses - simplywall.st
301,100 Shares in Treace Medical Concepts, Inc. $TMCI Acquired by Acuitas Investments LLC - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect - accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring A Potential 81% Upside - DirectorsTalk Interviews
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Rating of "Reduce" from Brokerages - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Treace Medical Concepts sees revenue fall in the fourth quarter - Jacksonville Daily Record
How New Analyst Targets Are Reframing The Treace Medical Concepts (TMCI) Investment Story - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts Reports Q3 2025 Financial Results - MSN
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Critical Analysis: Treace Medical Concepts (NASDAQ:TMCI) versus Adagio Medical (NASDAQ:ADGM) - Defense World
Treace Medical Concepts, Inc. (TMCI): Investor Outlook Highlights 83.77% Potential Upside - DirectorsTalk Interviews
Downgrade Watch: Will Treace Medical Concepts Inc stock hit new highs in YEARJuly 2025 Highlights & Detailed Earnings Play Alerts - baoquankhu1.vn
Treace Medical Concepts’ preliminary revenue down 9% in Q4 2025 - Medical Buyer
Treace Medical Issues Preliminary Q4 Results, Highlights Growth - TipRanks
Treace Medical Concepts, Inc. Provides Preliminary Revenue for the Fourth Quarter of 2025 - marketscreener.com
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue - The Manila Times
Treace Medical Concepts Reports Preliminary 2025 Revenue Results and Updates on Surgeon Adoption Trends - Quiver Quantitative
Published on: 2026-01-13 05:27:40 - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
How Treace Medical Concepts Inc. stock compares to industry benchmarksAnalyst Downgrade & Advanced Technical Analysis Signals - ulpravda.ru
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - The Manila Times
Will Treace Medical Concepts Inc. stock recover faster than market2025 Valuation Update & Growth Oriented Trade Recommendations - Улправда
Will Treace Medical Concepts Inc. stock return to pre crisis levels2025 Pullback Review & AI Optimized Trading Strategy Guides - ulpravda.ru
Will Treace Medical Concepts Inc. stock outperform Nasdaq indexDollar Strength & High Accuracy Swing Entry Alerts - Улправда
Dow Theory LettersTreace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - FinancialContent
Is Treace Medical Concepts Inc. stock oversold or undervaluedMarket Activity Report & Accurate Intraday Trade Tips - Улправда
How Treace Medical Concepts Inc. stock reacts to Fed rate cutsJuly 2025 Spike Watch & Precise Buy Zone Identification - Улправда
How Treace Medical Concepts Inc. stock benefits from tech adoptionJuly 2025 Update & Breakout Confirmation Alerts - Улправда
The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts - Benzinga
Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Low P/S - simplywall.st
How Recent Guidance Shifts Are Rewriting The Story For Treace Medical Concepts (TMCI) - Yahoo Finance
How Treace Medical Concepts Inc. stock performs during Fed tightening cycles2026 world cup usa national team round of 16 goalkeepers transition play odds analysis tactical review - Улправда
Treace Medical’s Earnings Call: Growth Amid Challenges - MSN
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 115% Potential Upside Amidst Market Challenges - DirectorsTalk Interviews
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Treace to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Treace Medical Concepts CEO John T. Treace to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Bunion-focused medtech CEO to speak at J.P. Morgan Healthcare Conference - Stock Titan
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Reduce" from Brokerages - MarketBeat
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):